<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="40382">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02580682</url>
  </required_header>
  <id_info>
    <org_study_id>XTCX2014-SFT</org_study_id>
    <nct_id>NCT02580682</nct_id>
  </id_info>
  <brief_title>Treatment of Sanfu Herbal Patch for Allergic Rhinitis: a Controlled Clinical Trial</brief_title>
  <official_title>Treatment of Sanfu Herbal Patch for Allergic Rhinitis: a Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To observe the efficacy of Sanfu herbal patch and Sanfu moxibustion on allergic rhinitis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Nasal Symptom Score(TNSS)</measure>
    <time_frame>three years</time_frame>
    <description>In TNSS, symptoms of nasal congestion , sneezing, nasal itching and rhinorrhea are assessed by scores ranging from 0 to 3. A score of 0 indicates no symptoms, 1 for mild symptoms that are easily tolerated, 2 for awareness of symptoms which are bothersome but tolerable and 3 is reserved for severe symptoms that are hard to tolerate and interfere with daily activity .TNSS is calculated by adding the score for each symptom together</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>visual analogue scale (VAS)</measure>
    <time_frame>three years</time_frame>
    <description>VAS is a 10cm scale to assess the impact of AR on life quality ranging from score of 0 to 10, which stands for &quot;no impact&quot; to &quot;serious impact</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rhinitis Quality of Life Questionnaire (RQLQ)</measure>
    <time_frame>three years</time_frame>
    <description>The RQLQ contains 28 questions to evaluate impairment of everyday life caused by symptoms of nose and eyes. Seven dimensions will be assessed, including daily life, sleep, non-nosal/optical symptoms, practical problems, nosal symptoms, optical symptoms and emotion. Every question should be answered by scores: 0 - not trouble, 1 - any trouble at all, 2 - somewhat troubled, 3 - moderately troubled, 4 - quite a bit of trouble, 5 - very troubled, 6 - extremely troubled.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>36-item Short-Form Health Survey (SF-36)</measure>
    <time_frame>three years</time_frame>
    <description>SF-36 consists of 36 items categorized as eight dimensions: social functioning (two items), role limitation-emotion (three items), mental health (five items), physical functioning (ten items), role limitation-physical (four items), bodily pain (two items), vitality (four items), general health (five items) and one question of health change in recent one year.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Allergic Rhinitis</condition>
  <arm_group>
    <arm_group_label>Sanfu herbal patch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>one kind of acupoint application which used in hot dog days of summer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sanfu moxibustion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>use moxibustion in hot dog days of summer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>combined method</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>use herbal patch and moxibustion together in hot dog days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sanfu herbal patch</intervention_name>
    <description>The formula of the patch consists of Huang Qi (Astagalus Membranaceus), Fu Zi (Aconiti Lateralis Radix Praeparata), Yan Hu Suo (Rhizoma Corydalis), Xi Xin (Herba As5ari), Bai Jie Zi (Semen Sinapis Albae) and Rou Gui(Cortex Cinnamomi), in a proportion of 2:2:1:1:2:1.</description>
    <arm_group_label>Sanfu herbal patch</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sanfu moxibustion</intervention_name>
    <description>Moxibustion is a kind of thermal therapy without any feeling of pain or swell.Moxibustion exerts its therapeutic effect by thermal power and the application of moxa.</description>
    <arm_group_label>Sanfu moxibustion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sanfu herbal patch and moxibustion</intervention_name>
    <description>use Sanfu moxibustion followed by Sanfu herbal patch</description>
    <arm_group_label>combined method</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The patients conform to the diagnostic criteria of allergic rhinitis;

          2. Sex unlimited;

          3. To be aged from 5-70;

          4. The course of the disease in more than one year

        Exclusion Criteria:

          1. Do not conform the inclusion criteria;

          2. The patients who allergic to adhesive plaster, drugs and application materials; The
             people who has scar constitution and skin injuries;

          3. The people who has chronic sinusitis History;

          4. The people who has paroxysmal disease of respiratory system like asthma;

          5. The people who accept the treatment of specific immunity therapy and system hormone
             therapy in recent a year;

          6. Pregnant women and nursing mothers;

          7. Tuberculosis and hepatitis patients; The people who's Ur, ALT, AST is higher than the
             normal value 2 times;

          8. The people who have mental disease;

          9. The people who smoking to more than 10 cigarettes per day for 10 years;

         10. the people who has other problem which is not suitable to participate in this project
             study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fengxia Liang, Doctor</last_name>
    <phone>+86 18971371818</phone>
    <email>315938821@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hubei university of TCM</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fengxia Liang, Doctor</last_name>
      <phone>+86 18971371818</phone>
      <email>315938821@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <lastchanged_date>April 14, 2016</lastchanged_date>
  <firstreceived_date>October 18, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Rhinitis, Allergic</mesh_term>
    <mesh_term>Rhinitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>we have recruited approximately sixty patients in tha last year, informations including contacting numbers, medical history, questionnaires and follow-up materials, we have not decided in which way we could share these data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
